A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Final published version, 1.16 MB, PDF document
| Original language | English |
|---|---|
| Journal | Acta Neuropathologica |
| Volume | 138 |
| Issue number | 2 |
| Pages (from-to) | 237-250 |
| Number of pages | 14 |
| ISSN | 0001-6322 |
| DOIs | |
| Publication status | Published - 2019 |
Bibliographical note
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. DOI: 10.1007/s00401-019-02026-8
- Alzheimer's disease, Frontotemporal dementia, Dementia with Lewy bodies, Progressive supranuclear palsy, Parkinson's disease, Amyotrophic lateral sclerosis, Multiple sclerosis, Neurodegenerative disease, Longevity, PLCG2, Phospholipase C Gamma 2
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 225518896